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CapB2 is recognized as a tyrosine kinase and is likely a vital factor in extracellular
polysaccharide synthesis in Staphylococcus aureus, but its pathogenicity function and
regulatory mechanism remain obscure. Here, we demonstrate that CapB2 enhances
bacterial virulence in a murine model. Mice infected with the wild type SA75 strain
exhibited significantly larger (P < 0.05) skin lesions from days 4 to 7 of infection than
those challenged with the capB2 mutant strain. The effect on virulence was reverted
by restoring the capB2 mutation to the wild type. The related components of the wild
type SA75 cell wall in the capB2 mutant strain (SA751capB2) were thinner than wild
type SA75 strain and the capB2 mutant complemented strain (SA751capB2-C), which
was determined by the transmission electron microscopy. The survival percentages
of the wild type strain SA75 and SA751capB2-C were significantly higher relative
to SA751capB2. The results of qRT-PCR studies also indicated that mutations in
regulatory gene sarA led to a drastic increase in capB2 gene transcription, with a 326-
fold increase of growth at 6 h compared with the wild type strain, suggesting that
sarA is a major negative regulator of capB2 expression. Taken together, these results
demonstrate that the expression of CapB2 promotes S. aureus virulence in a mouse
model of skin infection, and that capB2 gene transcription is regulated negatively by
SarA.
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INTRODUCTION
Staphylococcus aureus is a common bacterial pathogen which causes a wide range of human
diseases, ranging from relatively benign skin and tissue infections to complicated life threatening
diseases such as osteomyelitis, septic arthritis, and bacteremia. S. aureus pathogenicity is mediated
by bacterial components and secreted virulence factors such as surface-associated adhesins,
capsular polysaccharide (CP), and exotoxins. Studies have shown that CP is an important virulence
factor in S. aureus, and it is believed to enhance microbial virulence (Nilsson et al., 1997; Thakker
et al., 1998) in host immune evasion (Nanra et al., 2013).
More than 90% of S. aureus strains express CP, and 13 capsular serotypes have been described
to date (Arbeit et al., 1984; Karakawa et al., 1985; von Eiff et al., 2007). Polysaccharide capsules
corresponding to serotypes 1 and 2 (CP1 and CP2) are associated with heavily encapsulated
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mucoid strains, but are rarely encountered among clinical
isolates (Luong T.T. et al., 2002; Luong et al., 2003). By
contrast, CP5 and CP8 are both predominant among clinical
infection isolates (Sompolinsky et al., 1985; O’Riordan and
Lee, 2004), and are associated with microencapsulated strains
exhibiting non-mucoid colony morphology. The cap5 and
cap8 operons both contain 16 open reading frames, cap5A1
(cap8A1) through cap5P (cap8P), with the type-specific genes
situated in the central region of the operons (cap5HIJK or
cap8HIJK) (Sau et al., 1997a). CapB1, which forms a complex
with the C-terminal domain of transmembrane protein CapA1,
is probably a regulator of chain length in CP biosynthesis
(Sau et al., 1997b), and has been shown to exhibit tyrosine
kinase activity (Olivares-Illana et al., 2008). Whole genome
sequencing of S. aureus has demonstrated that the gene products
of capA2/capB2 (located elsewhere in the genome) are highly
similar to those of capA1/capB1 (Kuroda et al., 2001; Soulat et al.,
2006). However, despite CapB1 sharing more than 70% sequence
identity with CapB2, no kinase activity could be detected
for CapB1 in vitro. Of interest, the tyrosine kinase activity
of CapB2 is more efficiently activated by the transmembrane
stimulatory protein CapA1 than by the corresponding CapA2
activator (Kuroda et al., 2001; Soulat et al., 2006). Once
CapB2 has been activated, its tyrosine cluster is phosphorylated
(Grangeasse et al., 2012), indicating that CapB2 is probably
a vital factor in the synthesis and/or export of extracellular
polysaccharides.
The Staphylococcal accessory regular (sar) locus encodes
a DNA binding protein, SarA, which is a key pleiotropic
transcriptional regulator for the synthesis of extracellular
virulence proteins (Cheung and Zhang, 2002). The sarA gene can
regulate virulence expression dependently of agr (Cheung and
Zhang, 2002). And it can also activate certain virulence genes
by binding the promoter of the target gene directly (Cheung and
Zhang, 2002).
In the present study, we analyzed the role of capB2 in the
virulence of S. aureus by constructed an allelic replacement
mutant of S. aureus 75. Our results show that a capB2 mutant
of S. aureus is less virulence in the mice model of skin infection.
In addition, we investigated the capB2 expression regulated by
SarA.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Culture
Conditions
The bacterial strains and plasmids used in this study are described
in Table 1. S. aureus strain SA75 was isolated from a patient
with a purulent skin infection at the First Affiliated Hospital
in Wenzhou. Unless otherwise stated, Escherichia coli strains
were cultured in Luria-Bertani medium, and S. aureus strains
were grown in tryptic soy broth (TSB) medium, at 37◦C with
shaking at 200 rpm. The culture media were supplemented
with appropriate antibiotics when required (ampicillin at
100 mg/l, chloramphenicol at 10 mg/l and anhydrotetracycline
at 50 ng/ml).
TABLE 1 | Bacterial strains and plasmids used in this study.
Strains and
plasmixds
Description Source
Strains
S. aureus
SA75 Wild type, CP8-positive, clinical
MRSA strain isolated from an
abscess
Laboratory stock
SA751sarA Isogenic sarA deletion mutant in
SA75
Laboratory stock
SA751capB2 Isogenic capB2 deletion mutant in
SA75
This study
SA751sarA-C sarA mutant complemented with
pRBsarA
This study
SA751capB2-C capB2 mutant complemented with
pRBcapB2
This study
E. coli
DH5α Clone host strain Laboratory stock
DC10B dam+1dcm−1hsdRMS endA1
recA1; clone host strain
Laboratory stock
Plasmids
pKOR1 Shuttle cloning vector, temp
sensitive (CmrAmpr )a
Laboratory stock
pKcapB2 pKOR1 containing fragments
1500-bp upstream and 1500-bp
downstream of capB2 gene, for
capB2 mutagenesis (CmrAmpr )
This study
pRB473 Shuttle cloning vector (Cmr ) Laboratory stock
pRBsarA pRB473 with sarA and its promoter
(Cmr )
This study
pRBcapB2 pRB473 with capB2 and its
promoter (Cmr )
This study
aCmrAmpr, chloramphenical and ampicillin resistance.
DNA Manipulations
Genomic DNA extraction was performed as described previously
(Yu et al., 2014). Plasmid DNA extracted from E. coli strains was
purified according to the manufacturer’s instruction (Axygen,
Union City, CA, USA). To extract plasmid DNA from S. aureus
strains, 20 µl lysostaphin (2 mg/ml) was used with suspension
buffer S1 to re-suspend the collected cells from 10 ml overnight
culture, incubated at 37◦C for 1 h, and then processed following
the manufacturer’s instruction (TIANGEN, Beijing, China).
Construction of S. aureus capB2 Mutant
Strain by Allelic Replacement
In order to generate a capB2 mutant from SA75, genomic DNA
was extracted from S. aureus SA75 and the two sets of primers
listed in Table 2 were used to amplify DNA fragments 1.5-kb
upstream and downstream of capB2 from SA75 chromosomal
DNA. The amplified products were digested with HindIII and
then ligated with T4 DNA ligase to yield a 693 bp deletion
fragment (called 1capB2). The primers UP-F-attB2 and Dn-R-
attB1 were used to amplify 1capB2 fragment, yielding a PCR
product with attB sites at the 5′ and 3′ ends. The resulting
fragments were recombined with temperature-sensitive shuttle
plasmid pKOR1 to generate recombinant plasmid pKcapB2.
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TABLE 2 | Primers used in this study.
Primers Oligonucleotide (5′→3′)a
capB2-up-F- BamHI CGggatccGCACGCTCGGTGTTGTAAAG
capB2-up-R- HindIII CCCaagcttCTTCTTCGTGTATTCGTCAT
capB2-down-F- HindIII CCCaagcttGCATATTATGGGACTGATGA
capB2-down-R- XhoI CCGctcgagTTGATCTAAGTCCTGCATGA
UP-F-attB2 GGGGACCACTTTGTACAAGAAAGCTGGGTGC
ACGCTCGGTGTTGTAAAG
Dn-R-attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTTG
ATCTAAGTCCTGCATGA
SW-cp-F ATAGTTTAGTAAGCGACCTG
XW-cp-R TACAGGAAATCCGCATAAAT
Cp-BD-F ATGACGAATACACGAAGAAG
Cp-BD-R TCATGATTCATCAGTCCCAT
PstI-sarA-F AAAActgcagTAAACCAAATGCTAACCCA
BamHI-sarA-R CGCggatccAGTGCCATTAGTGCAAAAC
PstI-cap-19F AAAActgcagATTTTTGTTACTAGTTTGT
BamHI-cap-19R CGggatccTCATGATTCATCAGTCCCA
cap5K-F GTCAAAGATTATGTGATGCTACTGAG
cap5K-R ACTTCGAATATAAACTTGAATCAATGTTATACAG
cap8I-F GCCTTATGTTAGGTGATAAACC
cap8I-R GGAAAAACACTATCATAGCAGG
gyrB-F ACATTACAGCAGCGTATTAG
gyrB-R CTCATAGTGATAGGAGTCTTCT
cap-XF ACGAATACACGAAGAAGTA
cap-XR CCTCTGAAGTGATTACAATG
sarA-qtF GTTATCAATGGTCACTTATGC
sarA-qtR CTTGTGGTTGTTTGTAGTTT
aRestriction sites are indicated by lowercase letters; underlined sequences denote
recombination sites.
The resultant plasmid containing the 1capB2 gene deletion
was transferred first to E. coli DH5α and then to E. coli DC10B,
and subsequently electroporated into strain SA75. The allelic
exchange procedure was performed as described previously (Bae
and Schneewind, 2006). Putative transformants were screened
by PCR with LATaq DNA polymerase, using primer pairs SW-
cp-F/XW-cp-R and Cp-BD-F/Cp-BD-R. Deletion of the desired
gene was verified by PCR, quantitative reverse transcription-PCR
(qRT-PCR), and sequencing.
Construction of Complemented Strains
For complementation of the sarA gene and capB2 gene, the
deleted genes and their own putative promoters region were
amplified by PCR with Iproof High-Fidelity DNA polymerase
using primers PstI-sarA-F and BamHI-sarA-R for sarA, and
primers PstI-cap-19F and BamHI-cap-19R for capB2. The
PCR products were digested with BamHI and PstI, and the
fragments were ligated into shuttle plasmid pRB473 to generate
plasmid pRBsarA and pRBcapB2. The resultant plasmids were
transferred into E. coli DH5α and DC10B successively, and
finally electroporated into mutant strains SA751sarA and
SA751capB2. Successful uptake of the complementation plasmid
was confirmed by restriction mapping, PCR and sequencing of
PCR fragments. The presence of sarA transcription or capB2
transcription within the transformants was verified by qRT-PCR.
Capsular Genotype Detection
Capsular genotype was detected by PCR as described previously
(Verdier et al., 2007). Genomic DNA from strain SA75 was used
as template, with primers cap5k-F and cap5k-R for detection of
capsular type 5, and primers cap8I-F and cap8I-R for detection
of capsular type 8. PCR product sizes were 361 and 173 bp
for capsular types 5 and 8, respectively, and were confirmed by
sequencing.
Growth Curve
Staphylococcus aureus wild type strain SA75 and its derivative
strains were incubated overnight in 5 ml TSB at 37◦C with
shaking at 200 rpm. The overnight cultures were diluted in
30 ml TSB to obtain the same starting optical density (OD) at
562 nm. The growth of each strain was monitored by Microplate
Manager 6 (Bio-Rad, USA) software at 1 h intervals for a total
of 12 h.
S. aureus Survival Analyze in Human
Blood
Blood samples from healthy donors were collected in 10 mg/ml
heparin anticoagulation tubes. The ability of S. aureus SA75
and SA751capB2 to survive in human blood was determined
under post-logarithmic growth phase. The strains were analyzed
after washed twice and suspended to an OD of 0.6 at 562 nm.
Then, 1 ml of heparinized human blood was inoculated with
100 µl aliquot of these suspensions and was incubated at
37◦C. After 7 h, bacteria cells were appropriate diluted to
detect the endpoint numbers of CFU. The survival rate of
the bacteria cells was determined by comparing to the initial
inoculum.
Mouse Model of Skin Infection Assay
Animal studies were approved by the Institutional Animal
Care and Use Committee at Wenzhou Medical University. We
confirm that all animal care and methods were performed
in accordance with the guidelines and regulations approved
by the Administration of Affairs Concerning Experimental
Animals in China. The skin abscess model was performed
as described previously (Li et al., 2012). Female, 4- to 6-
week old, BALB/C-nu mice were used in the study. The
mice were housed for 7 days before inoculation with food
and water ad libitum. S. aureus cultures were grown to post-
exponential phase, washed with sterile phosphate-buffered saline
(PBS), and then suspended in PBS to achieve a concentration
of 1.0 × 105 CFU/100 µl. The bacterial numbers were
confirmed by plate counts. After the mice were anesthetized
with diethyl ether, each mouse was injected subcutaneously
with 100 µl of either S. aureus suspension or PBS. Skin
lesions developing on test animals were observed daily, and the
abscess area calculated using the formula length (L) × width
(W). The values of L and W for each infected mouse
were determined by caliper. Dermonecrosis was observed
and recorded for 10 days, following which all animals were
euthanized.
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Electron Microscopy Study on Abscess
Tissue
Overnight cultures of S. aureus SA75, capB2 mutant and the
complemented strains were harvested and washed twice with
sterile PBS, and then suspended to achieve a concentration of
1.0 × 108 CFU/100 µl. Mouse model of subcutaneous abscess
was performed as above. The abscess tissue was obtained at the
fourth day of infection. Samples were fixed and processed further
for transmission electron microscopy.
RNA Extraction, cDNA Synthesis, and
Quantitative Reverse Transcription-PCR
(qRT-PCR)
The quantitative Real-Time PCR was performed according to
the MIQE guidelines. For RNA isolation, S. aureus strains were
diluted 1:100 in TSB from overnight cultures and grown to
post-exponential phase at 37◦C with shaking at 200 rpm. Total
RNA was isolated and purified using a PureLink RNA Mini
Kit (Invitrogen, Carlsbad, CA, USA); 2 µg purified RNA was
then used to obtain cDNA using a PrimeScript RT reagent kit
(TaKaRa, Japan) following the manufacturer’s instructions. The
resultant cDNA was amplified using a SsoFas EvaGreen Supermix
kit (Bio-Rad, USA) with the Bio-Rad CFX96 Manager software.
Oligonucleotide primers used are listed in Table 2. Wild type
strain SA75 was used as a control (relative expression = 1), and
gyrB was used as a reference gene to investigate genes of interest.
RNA transcript levels were calculated by the method of delta delta
Ct (11Ct) (Montgomery et al., 2012). Data analysis was carried
out using Bio-Rad CFX software. Each reaction was performed in
triplicate.
Statistical Analysis
Skin abscesses in the mouse infection model were compared
with one-way analysis of variance (ANOVA) using SPSS Statistics
17.0. Results were considered statistically significant if P-values
were < 0.05. Relative expression levels resulting from qRT-PCR
were analyzed using GraphPad Prism 5.0 software.
RESULTS
Capsular Genotype and Growth Curve
Analysis
In order to rule out the potential influence of the capB2 deletion
on bacterial growth rate, the growth curves of strains SA75,
SA751capB2, and SA751capB2-C were monitored hourly. The
growth curves of the three strains were measured in TSB medium
at the same starting OD of 562 nm, with TSB medium used as a
blank control. There were no substantial differences in growth
curves among all three strains. The capB2 gene was expressed at
the indicated time point (3, 6, 9, 12 h) and assessed in strain SA75,
with expression shown to be highest at the 6 h time point.
Deletion of capB2 in S. aureus
The capB2 deletion was introduced by allelic replacement into
S. aureus strain SA75, yielding the mutant strain SA751capB2.
High-efficiency cloning strain E. coli DC10B was used as an
intermediate host instead of S. aureus RN4220 in the study in
order to improve the transformation efficiency. To confirm the
deletion of capB2,SA751capB2 was amplified with primers SW-
cp-F and XW-cp-R using LA Taq DNA polymerase. The band
size in strain SA751capB2 reflected a 693 bp deletion compared
to the wild type strain. The relative expression of capB2 in strain
SA751capB2 was dramatically decreased relative to that of strain
SA75 (Figure 1).
Absence of capB2 Decreased S. aureus
Viability in Human Blood
To determine the contribution of capB2 in the pathogenicity
of S. aureus, we compared the relative viability of S. aureus
SA75 and SA751capB2 in human blood. After 7 h incubation,
the survival percentages of the wild type strain SA75 and the
complemented strain SA751capB2-C were significantly higher
relative to SA751capB2 (Figure 2).
Deletion of capB2 Decreases Virulence
of S. aureus SA75 in a Skin Infection
Model
To determine the role of capB2 in the pathogenesis of S. aureus,
4-to-6 week old BALB/C-nu mice were subcutaneously injected
with 1.0 × 105 CFU of strains SA75, SA751capB2, or
SA751capB2-C. As shown in Figure 3b, the resulting abscess
sizes in mice inoculated with the capB2 mutant strain were
smaller than the lesion sizes among animals infected with SA75 or
the complemented strain SA751capB2-C. The lesions remained
until the end point of the experiment (Figure 3a). The overall
rates of skin lesions were similar between the wild type and the
complemented strain.
As shown in Figure 3a, animals challenged with 1.0 × 105
CFU of SA75 had significantly larger (P < 0.05) skin lesions
from the fourth day to the seventh day of infection than
animals challenged with an equivalent amount of SA751capB
Likewise, significant differences between the SA751capB and the
FIGURE 1 | Deletion of capB2 in S. aureus. Gene gyrB was used as the
reference gene; the expression of capB2 in strain SA75 was regarded as 1.
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FIGURE 2 | The suvival rate of S. aureus derivatives in human blood. The number of CFU was detected at 0 and 7 h to calculate the rates of survival for
S. aureus strains SA75, SA751capB2, and SA751capB2-C exposed to human blood.
FIGURE 3 | Results of mouse skin infection model experiments. (a) Comparison of abscess size (area) of BALB/C-nu mice infected with wild type (SA75),
isogenic capB2 mutant (SA751capB2), and capB2-complemented (SA751capB2-C) strains strains; (b) Skin lesions resulting from S. aureus infection (picture taken
at day 10 of infection). Differences in the size/area of skin abscesses were compared by one-way analysis of variance (ANOVA) using SPSS Statistics 17.0.
FIGURE 4 | Electron microscopy study. (A) Transmission electron
micrograph of cell walls of S. aureus SA75 (B) the capB2 mutant strain (C)
and the complement strain.
SA751capB-C strains were observed from the second day to the
ninth day of infection. These data demonstrate that the presence
of capB2 in S. aureus promotes bacterial virulence.
Electron Microscopy Study
To analyze the influence of the deletion of capB2 gene in S. aureus
SA75, we used the transmission electron microscopy to detect the
difference between S. aureus SA75, SA751capB and SA751capB-
C strains. As shown in Figure 4, the related components of
S. aureus SA75 cell wall in SA751capB was thinner than SA75
and SA751capB-C.
FIGURE 5 | Effect of sarA on expression of capB2. Relative transcription
of the capB2 gene was detected by qRT-PCR. Reference gene gyrB was
used as the relative expression gene; the expression of capB2 in strain SA75
was regarded as 1.
Effect of sarA on capB2 Expression
In our previous work, we constructed a sarA mutant strain. To
eliminate the possibility of a second mutant, we constructed
a sarA-complemented strain containing a plasmid bearing the
sarA gene. Since the transcriptional expression of capB2 was
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highest at the 6 h time point, we selected that time point to
assess expression differences among the three strains. The effect
of sarA on expression of capB2 was assessed by qRT-PCR. As
shown in Figure 5, deletion of sarA had a dramatic effect on
capB2 expression, with a 326-fold increase at 6 h of growth
compared with that of the wild type strain. The difference in
capB2 expression was thus reversed by complementation of sarA.
These results suggest that sarA represses the expression of capB2.
DISCUSSION
Capsular polysaccharide produced by S. aureus has been
acknowledged as an important virulence factor for bacterial
infection. Methods for S. aureus capsule serotyping include
enzyme-linked immune sorbent assay (ELISA) inhibition, colony
immune blotting, and double immune diffusion assay (the
gold standard). However, all of them are based on the
availability of specialized antibodies, and are not suitable
for rapid capsule serotyping. Grunert et al. (2013) have
developed a high-throughput method to identify capsular
serotypes 5, 8 and NT (non-typable). DNA sequence analysis
of S. aureus has determined that the cap5HIJK and cap8HIJK
genes are the primary capsular type-specific genes. This
information allowed us to identify the capsular genotype
of SA75 using type-specific oligonucleotide primers (Verdier
et al., 2007) designed against the cap5K and cap8I genes,
with the results demonstrating that SA75 belongs to capsular
type CP8.
Since the skin infection model was shown to be more sensitive,
the role of CapB2 in S. aureus pathogenicity was evaluated
using the skin infection model. Notably, the capB2 deletion
decreased virulence in the mouse model of S. aureus skin
infection, but full virulence was restored by transformation with
the complementation plasmid containing the capB2 gene. Neither
the capB2 mutant strain nor the complementation strain showed
any difference in bacterial growth compared with the wild type
strain when grown in TSB medium. Of important, the mutant
of capB2 in S. aureus strain resulted in difference in the related
components of cell wall. The role of CP in the pathogenesis of
S. aureus infection has been reported by a number of studies
(Baddour et al., 1992; Luong and Lee, 2002; O’Riordan and Lee,
2004; Nanra et al., 2013), which found that expression of CP5 or
CP8 can enhance bacterial virulence both in vitro and in vivo.
Taken together, we conclude that the decrease in virulence of the
capB2 mutant strain is likely due to decreased synthesis of CP
rather than the effect on overall growth.
Similar to other virulence proteins, CP and CapB2 are also
regulated by a complex regulatory network. Luong T. et al.
(2002) investigated the regulation of S. aureus CP8 expression
by the global regulators agr and sarA, and found that the CP8
expression was positively regulated by agr and sarA, with agr
being the major activator. However, our results demonstrate that
capB2 expression was dramatically repressed by sarA, suggesting
that SarA is a negative regulator of capB2 expression. The
difference in regulation may be due to the complex regulatory
network present in S. aureus, with the sarA interface within
the regulatory network controlling the expression of virulence-
associated proteins (Arvidson and Tegmark, 2001). In addition,
the expression of CP is also influenced by several regulatory
proteins. The regulation of CP by the two-component system
KdpDE has been reported by Zhao et al. (2010), who found
that CP expression was reduced in the kdpDE mutant strain,
and that positive regulation occurred via the phosphorylation of
KdpE. Furthermore, Lei and Lee (2015) found that RbsR (a Lacl
family of repressor) positively regulates cap gene expression by
directly binding to the cap operon promoter region, as evidenced
by electrophoretic mobility shift assays (EMSA). In brief, the
complexity of virulence regulatory networks in S. aureus is such
that a single virulence protein may be controlled by a remarkable
number of regulators.
In summary, CapB2 is a probable virulence gene in S. aureus
infection, with deletion of capB2 resulting in decreased virulence
in a mouse model of skin infection. SarA, on the other hand, is
a negative regulator of capB2 expression, but further in-depth
studies are required to determine if it directly regulates capB2.
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